>YP_009408395.1 |surface glycoprotein [NY_014 poxvirus]
MNLYILSLIIYFATCSWCYETCMRKSALYHDNNLDRVEDNKDDVASLPYKYLQVVHQRES
SRLLATFNWTSISNSVREEFVKRCDINGTYLYNYTIAISMIINSTEELLTSPIQTTTQTP
TPSPTQYYYTTPLPTSIVPYNQSNNNVSIISIQILSKILGVNESELTSYLITHINNTVVY
NETYNNTVVYNEASNNNTLNGNIGLFEINNCYNVSVADASFRITLVNETSEEIVLMLKGT
SASDTFISSDNITECLRTLINNTSNNTDVTITENVNVTSNCDKCSMDLMTSVVPIVTEFN
NTLEKIGAKYSNTTYSYYHCKLTTNSNCNELINLNEIINNITLTNIISSSSKTNTRKRRD
LNPEIGFSTPKELDCLYESYGVKDDVSHCFASPRHRRSDDKEYIEMKLLDHAKRDLGIDS
VIPRGTTHFQVGVSGASGGVVGDSSPFQNVKSRASLLAEKIMPKVPITTTEDDLYATVNK
QAKLPAGVKSTPFTEAVVSTINQKLSSVKDVTYASLELPRSSGYIHRPSESVIYSTIRRP
RISSSSSSDFEDIDTVVKEYNQKYGGRVRTLSSSSDFEDIDTVVKEYNQKYGGRVRTLSS
NSDFEDIDTVVKEYNQKYGNAMTRGRSTSPKPDPLYSTVKKTPKSLAAGVEIATKQTEYS
ILPDVNTGSSIMTPLTRRGATRRPKRPSPPSSNNLPPLPPNPPPRNPRPQLPPRDDSSPP
RRPPPPLPPKPVPAVPPRDSQPDKKGFSKFVSPRRCRRASSGVICGLIQSRPNDDTYSLL
QPPNRNYPQYEEVGNGIARNNVPVIGDKRSKKYTSSMTKISTKFDKSMAFGAAMLLTGQQ
AINQQIRSTALIRKDQMSKEEKIFEAVSMGLSSIGSTLTTAGMVAGPKLMIAGMGVSFIA
GIIDTVKDIYYLLSGAERPEDPVIKLFNTYSDLVSDSNKMGVRKCLTPGEDTIIFMAYKN
DSSFKPNIDNAIYFLDVINSEILYLNTSNLVLEYQLKVACPIGTLRSVDVDITAYTVLYD
TSDNIKRYKFVRLATLLSKHPVIRLTCGLDATLVIKPYEVPISDMQLLKMATPGEPESTK
SIPSDVCDKYPLKKFYLLASGCPYDTSQTFIVHTTCSILLKTATWDQFRNRWVLQNPFKQ
EGTFKQLFTFSKYDFNDTIIDPNGVEGHASFCTNKSSNQCFWSEPMILEDVTSCNSRTRK
IYVKLGLFNTGGFNSFVLNCPSGSTPTYIKDKNTDNSNFIIELPVGDYGTAKLYSSTKQS
RIAVFCTHNYDKRFKSDIIVLIFDRFSSLSFTSIDTTGVYGKNTLFYRLSGGMPFRSLFC
DNRRRAGCNYAGIPFNEESVEIDVHHGSEIMFKETYDANSVDPVIISKSKTHFPSPLNIK
FHVNNLGNGYKNHDSFWKDAKNKKRTYSAITLKISPCTIRNKNIDFGPFVSNMVYLQSTS
YDYGDGSKYTFKSVNKTNHECEASLDLTSKEVIVTCPAFSIPRNISKYEGLCFTIVTSKD
HCATNDDGLKSHGYEKEDAYKQRYCHHHWLYNIKPYDYYCMDSYFKHRFPDYDPCNSYIN
VEYRDTWIESKVLQQPPYTFEFIHDDSNEYVDKEISNKLNDLYNEYKNIMEYSDGSLPAS
INRLAKALTLEGREITSVNIDGNLLDIAYQADKEKMIEIQNKIDDITRDLFIHTLSDKDI
KDIIESEEGKRCCIIDVKNNHVEKYYPIDNYLCGTLDDYIYTSVETNKSYVLVNDTYMSY
DYLEASGIVVLSCYEMTIISLDTKDAKDAVENEIIESAVAEALNDMFKEFDKNVSAILIK
EEDNYLNNKDIYNIIYIIGSAILLLLVIVLILVMYIALNRYKTRKYKLIKKYDNISIKSE
HHNSLETISMEIIDH
>AXN74997.1 |surface glycoprotein [Akhmeta virus]
MNLHRLSLAIYLTATCSWCYETCMRKSALYHDNKLGHMDESQDNVASLPYKYLQLVHKRE
RSRLLATFNWPSITNSVRGEFIKICNINGSYIYNYTIAVSMVINSTEELPVTPITTVSPQ
LTTHPLTTPQLTTHPLTTPPQTTPPPTTLPPLTTPSYDQRSNNNVSVISIQILSRILGVN
ETVLTNYLITHRNATADNTTSVINNHTVDDATFGNNTLNGSIGVLNITNCYNVSVLDASF
EITLVNDTSEEIVLMLRGTSSSDTFISSDNITECLKALINNASNVSDVSITQNINVTSNC
DKCSMNLMTSVIPIVSEYNDTLEKIGVKKDDNTTHAYYYCKLTTNSTCNELINLDSVINN
ITLTNIISSSSTATNNKRKRRDLDNEFEYSTSKELDCLYESYGVNDDVRHCFASPRHRRS
DDKQAYIEMKLLDHAKRDLGLDRIIPRGTTHLQVGASGASGGVVGDSSPFQNVKSRASLL
AEKIMPRVPITATESDLYAVVNKQPKLPAGVKSTPFTEALASTITQKLSSAREVTYASLN
LPRSSGVIHKPPDSVIYSTIRRTRLPSDSDSDFEDIQTVVREYNERYGRRVSRTSSSSSS
DFEDVGAVAREYNEKYGSDSRLRTVSSSSSDFEDIETVVREYKEKYGNAMTKGRSSSPKP
DQLYSTVKKTPKSIASGVEIVTSQSGYSIIPDVNTGSSIMTPLTRRGATRRPKQPTYNDD
LQAPLNPPPRNPRRPLPQRGYHPQVPQDDDYSLPQVPRRDGSPPPLPPRRPPPLPPKPAG
QVPPRDQPDKGFSKFVSPRRCRRSSSGVICGMLQSRPNDDTYSLLQRPNPEPEYAEVGNG
VPRNNVPVIGNKHSKKYTSSMSKISTKFDKSMAFGAAMLLTGQQAISQQSRSSVLSKKDQ
MSKEEKIFEAVTMSLSAIGSTLTSAGMVGGPKLMIAGMGITAITGIIDTIKDIYQLFSGY
EKPEDPVIKLFNTYSGLVSNNDKMGVRKCLTPGEDTIIYMAYRNDSSFKQNNDAMALYFL
DVIDSEILYLNTSNLVLEYQLKVACPIGTLRSMDVDITAYTILYDTSDNIKKYKFVRLAT
LLSKHPVIRLTCGLAATLVIKPYEVPISDMQLLKMATPGEPEFTRSIPSDVCDRYPLKKF
YLLASGCPYDTSQTFIVHTTCSILLKTATWDQFRNRWVLQNPFRQEGTYKQLFTFSKYDF
NDTIIDPNGVAGHASFCTNRSSNQCFWSEPMILEDVSSCNSRTRKIYVRLGRFESSGFNS
FVLNCPTGSTPTYIKDKNTENGNVIIELPVGDYGTAKLYSSTKASRIAVFCTHNYDKRFK
SDIIVIIFDYGTVSYSSIYTGGMSGKRQLFNKFSDGLPYRSTYCDNRRSGCYYAGIPFNE
DSVEADLHYGPEIMFKETYDANSIDQRVITKSKTHFPSPLSVKFIVDNLGHGYNNPNAFW
EDAKTKKRTYSAMSIKILPCTMRNKNVEFGPVISNMLYLQSISQNYGDGSTYTFKPVNSA
EHDCESTLDLTSKEVTVSCPAFSIPRNVSKYEGICFSVTTSKDHCATNNGWLKSRGYGKN
DANRGRSCYHHWFYISRSLDYYCSHQDDWKSTWPDYDPCKSYIYIEYRDTWIESNVLQQP
PYTFEFTHDNSNEYVNKEISDKLNDLYNEYKNIMEYSDGSLPASINRLAKALTSEGREIA
SVNIDGNLLDIAYQADKEKMADIQTRINDITRDLFIHTLSDKDIKDIIESEEGKRCCIID
VKNNRVEKYYPVDNYLCGTLDDYIYTSIEHNKSYVLVNNTYMEYDYLASSGVVVLSCYEM
TIISLDTKDAKDAIEDEIVASAVAEALNDIFKEFDKNVSAIIIKEEDKYLNSPHSNSQDI
YNIIYIIGGSILVLLVIILILAIYIARNKYRTRKYKIMKYDNRSIKSEHHNSLETVSMEI
MDNRY
>QED21095.1 |surface glycoprotein [Alaskapox virus]
MNLHRLSLAIYLTATCSWCYETCMRKSALYHDNQLGHEEDNQDSVASLPYKYLQVVNQRE
RSRLLATFNWTGIAEGVRNEFIKICDINGTYLYNYTIAVSMIYSTEELPTVPPITTYEPS
TYNYTIGNSTEEYVTPSPTPTYTPVTTPLPTSAVPYDQRSNSNVSTISIQILSKILEVNE
TELTNYLIAHKNVTVDNNITINSTTVNNTTVDDETSDNNTLHGNIGFLEINNCYNVSVSD
ASFKITLVNDTSEEIVLMLTGTSSSDTFVSSTNITECLRTLINNASNISDVRITQNMNVT
SNCDKCSMNLMSSVIPVVDEFNNTLKKIGVKYSNTTHSYYHCKLTTNSTCEELIDLDEVI
NNITLTNIISSSAKTNTRKRRDLNPDIGFSTSKELDCLYKSYGVNDDISHCFASPRRRRS
DDKKEYIEMKLLDHAKKDLGIDRVLPKGTTHFQVGVSGASGGVVGDSSPFQNVKSRASLL
AEKIMPRVPITATEAELYATVNRQTKLPAGVKSTPFTEALASTINQKLSSVKEVTYASLN
LPGSSGYVHRPSDSVIYSSIRRSRLPSDSDSDFEDIQTVVRDYNERYGRRVSRTQSSSSS
DFEDIDTVVREYNEQKYGASRVRTPSSSSSDFEDIDTVVKEYREKYGGAMAKGRSSPKPD
PLYSTVKKTPKGLAAGVEIVTKQTDYSLLPDVNTGSSIMTPLTRRGATRRPKRPSPPPRE
DLPPLPPNPPPRNPRPWLPPRDDSSSPPRRPPPPLPPKPVPAVPPRDAQPDKKGFSKFVS
PRRCRRASSGVICGMIQSRPNDDTYSLLQRPKIEPEYAEVGNGVPKNNVPVIGNKHSKKY
TSSMSKISTKFDKSAAFGAAMLLTGQQAISQQTRLSALSRKDQMSKEERIFEAVSMGLST
IGSTLTTAGMVGGPKLMVVGMGISMISGIIDTVKDIYYLLSGYEKPEDPIITFFNTYSSL
VSNSNKMGVRKCLTPGEDTIIFMAYKNDSSFKPNIDKTAMYFLDVINSEILYLNTSNLVL
EYQLKVACPVGTLRSVDVDITAYTILYDTSDNIKRYKFVRLATLLSKHPVIRLTCGLATT
LVIKPYEVPISDMQLLKMATPGEPESTKSIPSDVCDKYPLKKFYLLAGGCPYDASQTFIV
YTTCSILLKTATWDQFRNRWVLQNPFRQEGMYKQLFTFSKYDFNDTIIDPNGVAGHASFC
TNKSSSQCFWTEPMILEDVTSCNSRTRKIYVKLEVFNGAGFNSFVLNCPSGSTPTYIKDK
NTPNDNFIIELPVGDYGTAKLYSSTKQSRIAVFCSHNYDKRFKSDIIVLIFDRFTRFSFT
SINTESVYGRNKLFIETSVGMPFRSLFCDNRRPGCYYAGIPFSEDSVESHTHYSSEIMLK
ETYDANSIDQRIITKSKTHFPSPISVKFNVDKLGNAYKNPNSFWKDAKNKKRTYSAITLK
IIQCTARNKAIEFGRIVSNMAYLQSTTRDYGDGNKYKFNSLNKTNHECEAILDLTSREVT
VTCPAFSIPRDVSTHEGLCFIVTTSKDHCATNDDGVKSDGYGKEDGHKQRYCRHHWAYGI
KPYDFYCMSVGWVHNFPDYDPCNSYIHIEYKDIWVESKVLKRPPYTFEFTHDNSNEYVNK
EISDKLNDLYNEYKKIMEYSDGSLPASINRLAKALTAEGRQIASVNIDGNLLDIAYQADK
EKIINIQNRISDITKDIFIHTLSDKDIKDIIESEEGKRCCIIDVKNNHVEKYYPVDNYLC
GTLDDYIYTSVDTNKSYVLVNDTYMSYDYLEASGVVVLSCYEMTIISLDTKDAKDAIEDE
ILESAVAEALNDMFMEFDKNVSAIIIKEEDNYLNNKRDIYNIIYIIGSAILSLLVIVLIL
VMYIALNKYKTRKYKLITKYDNMSIKSEHHNSLETISMEIIDH
>QNQ32151.1 |surface glycoprotein [Severe acute respiratory syndrome coronavirus 2]
MFVFLVLLPLVSSQCVNLTTRTQLPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFS
NVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYFASTEKSNIIRGWIFGTTLDSKTQSLLIV
NNATNVVIKVCEFQFCNDPFYHKNNKSWMESEFRVYSSANNCTFEYVSQPFLMDLEGKQG
NFKNLREFVFKNIDGYFKIYSKHTPINLVRDLPQGFSALEPLVDLPIGINITRFQTLLAL
HRSYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETKCTLK
SFTVEKGIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNATRFASVYAWNRKRISNCVAD
YSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGKIADYNYK
LPDDFTGCVIAWNSNNLDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGSTPCNGAE
GFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVNFNFN
GLTGTGVLTESNKKFLPFQQFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVITPGTNT
SNQVAVLYQDVNCTEVPVAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEHVNNSYECDI
PIGAGICASYQTQTNSPRRAQSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTT
EILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLNRALTGIAVEQDKNTQEVFAQ
VKQIYKTPPIKDFGGFNFSQILPDPSKPSKRSFIEDLLFNKVTLADAGFIKQYGDCLGDI
AARDLICAQKFNGLTVLPPLLTDEMIAQYTSALLAGTITSGWTFGAGAALQIPFAMQMAY
RFNGIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTASALGKLQDVVNQNAQALNTLVK
QLSSNFGAISSVLNDILSRLDKVEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRASANL
AATKMSECVLGQSKRVDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHD
GKAHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQPE
LDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELG
KYEQYIKWPWYIWLGFIAGLIAIVMVTIMLCCMTSCCSCLKGCCSCGSCCKFDEDDSEPV
LKGVKLHYT
>QOP88023.1 |surface glycoprotein [Severe acute respiratory syndrome coronavirus 2]
MFVFLVLLPLVSSQCVNLTTRTQLPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFS
NVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYFASIEKSNIIRGWIFGTTLDSKTQSLLIV
NNATNVVIKVCEFQFCNDPFLGVYYHKNNKSWMESEFRVYSSANNCTFEYVSQPFLMDLE
GKQGNFKNLREFVFKNIDGYFKIYSKHTPINLVRDLPQGFSALEPLVDLPIGINITRFQT
LLALHRRYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETK
CTLKSFTVEKGIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNATRFASVYAWNRKRISN
CVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGKIAD
YNYKLPDDFTGCVIAWNSNNLDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGSTPC
NGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVN
FNFNGLTGTGVLTESNKKFLPFQQFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVITP
GTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEHVNNSY
ECDIPIGAGICASYQTQTSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEIL
PVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLNRALTGIAVEQDKNTQEVFAQVKQ
IYKTPPIKDFGGFNFSQILPDPSKPSKRSFIEDLLFNKVTLADAGFIKQYGDCLGDIAAR
DLICAQKFNGLTVLPPLLTDEMIAQYTSALLAGTITSGWTFGAGAALQIPFAMQMAYRFN
GIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTASALGKLQDVVNQNAQALNTLVKQLS
SNFGAISSVLNDILSRLDKVEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRASANLAAT
KMSECVLGQSKRVDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGKA
HFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQPELDS
FKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE
QYIKWPWYIWLGFIAGLIAIVMVTIMLCCMTSCCSCLKGCCSCGSCCKFDEDDSEPVLKG
VKLHYT
>QOY79275.1 |surface glycoprotein [Severe acute respiratory syndrome coronavirus 2]
MFVFLVLLPLVSSQCVNLTTRTQLPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFS
NVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYFASTEKSNIIRGWIFGTTLDSKTQSLLIV
NNATNVVIKVCEFQFCNDPFLGVYYHKNNKSWMESEFRVYSSANNCTFEYVSQPFLMDLE
GKQGNFKNLREFVFKNIDGYFKIYSKHTPINLVRDLPQGFSALEPLVDLPIGINITRFQT
LLALHRSYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETK
CTLKSFTVEKGIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNATRFASVYAWNRKRISN
CVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGKIAD
YNYKLPDDFTGCVIAWNSNNLDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGSTPC
NGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVN
FNFNGLTGTGVLTESNKKFLPFQQFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVITP
GTNTSNQVAVLYQGVNCTEVPVAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEHVNNSY
ECDIPIGAGICASYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTI
SVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLNRALTGIAVEQDKNTQE
VFAQVKQIYKTPPIKDFGGFNFSQILPDPSKPSKRSFIEDLLFNKVTLADAGFIKQYGDC
LGDIAARDLICAQKFNGLTVLPPLLTDEMIAQYTSALLAGTITSGWTFGAGAALQIPFAM
QMAYRFNGIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTASALGKLQDVVNQNAQALN
TLVKQLSSNFGAISSVLNDILSRLDKVEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRA
SANLAATKMSECVLGQSKRVDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPA
ICHDGKAHFPREGVFVSNGTYWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDP
LQPELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDL
QELGKYEQYIKWPWYIWLGFIAGLIAIVMVTIMLCCMTSCCSCLKGCCSCGSCCKFDEDD
SEPVLKGVKLHYT
>QJR88113.1 |surface glycoprotein [Severe acute respiratory syndrome coronavirus 2]
MFVFLVLLPLVSSQCVNLTTRTQLPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFS
NVTWFHAIHVSGTNGIKRFDNPVLPFNDGVYFASTEKSNIIRGWIFGTTLDSKTQSLLIV
NNATNVVIKVCEFQFCNDPFLGVYYHKNNKSWMESEFRVYSSANNCTFEYVSQPFLMDLE
GKQGNFKNLREFVFKNIDGYFKIYSKHTPINLVRDLPQGFSALEPLVDLPIGINITRFQT
LLALHRSYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETK
CTLKSFTVEKGIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNATRFASVYAWNRKRISN
CVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGKIAD
YNYKLPDDFTGCVIAWNSNNLDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGSTPC
NGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVN
FNFNGLTGTGVLTESNKKFLPFQQFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVITP
GTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEHVNNSY
ECDIPIGAGICASYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTI
SVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLNRALTGIAVEQDKNTQE
VFAQVKQIYKIPPIKDFGGFNFSQILPDPSKPSKRSFIEDLLFNKVTLADAGFIKQYGDC
LGDIAARDLICAQKFNGLTVLPPLLTDEMIAQYTSALLAGTITSGWTFGAGAALQIPFAM
QMAYRFNGIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTASALGKLQDVVNQNAQALN
TLVKQLSSNFGAISSVLNDILSRLDKVEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRA
SANLAATKMSECVLGQSKRVDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPA
ICHDGKAHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDP
LQPELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDL
QELGKYEQYIKWPWYIWLGFIAGLIAIVMVTIMLCCMTSCCSCLKGCCSCGSCCKFDEDD
SEPVLKGVKLHYT
>QOR63226.1 |surface glycoprotein [Severe acute respiratory syndrome coronavirus 2]
MFVFLVLLPLVSSQCVNLTTRTQLPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFS
NVTWFHAIHVSGTNGTKGFYNPVLPFNDGVYFASTEKSNIIRGWIFGTTLDSKTQSLLIV
NNATNVVIKVCEFQFCNDPFLGVYYHKNNKSWMESEFRVYSSANNCTFEYVSQPFLMDLE
GKQGNFKNLREFVFKNIDGYFKIYSKHTPINLVRDLPQGFSALEPLVDLPIGINITRFQT
LLALHRSYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETK
CTLKSFTVEKGIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNATRFASVYAWNRKRISN
CVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGKIAD
YNYKLPDDFTGCVIAWNSNNLDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGSTPC
NGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVN
FNFNGLTGTGVLTESNKKFLPFQQFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVITP
GTNTSNQVAVLYQGVNCTEVPVAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEHVNNSY
ECDIPIGAGICASYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTI
SVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLNRALTGIAVEQDKNTQE
VFAQVKQIYKTPPIKDFGGFNFSQILPDPSKPSKRSFIEDLLFNKVTLADAGFIKQYGDC
LGDIAARDLICAQKFNGLTVLPPLLTDEMIAQYTSALLAGTITSGWTFGAGAALQIPFAM
QMAYRFNGIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTASALGKLQDVVNQNAQALN
TLVKQLSSNFGAISSVLNDILSRLDKVEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRA
SANLAATKMSECVLGQSKRVDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPA
ICHDGKAHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDP
LQPELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDL
QELGKYEQYIKWPWYIWLGFIAGLIAILMVTIMLCCMTSCCSCLKGCCSCGSCCKFDEDD
SEPVLKGVKLHYT
>QOT53297.1 |surface glycoprotein [Severe acute respiratory syndrome coronavirus 2]
MFVFLVLLPLVSSQCVNLTTRTQLPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFS
NVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYFASTEKSNIIRGWIFGTTLDSKTQSLLIV
NNATNVVIKVCEFQFCNDPFLGVYYHKNNKSWMESEFRVYSSANNCTFEYVSQPFLMDLE
GKQGNFKNLREFVFKNIDGYFKIYSKHTPINLVRDLPQGFSALEPLVDLPIGINITRFQT
LLALHRSYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETK
CTLKSFTVEKGIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNATRFASVYAWNRKRISN
CVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGKIAD
YNYKLPDDFTGCVIAWNSNNLDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGNTPC
NGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVN
FNFNGLTGTGVLTESNKKFLPFQQFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVITP
GTNTSNQVAVLYQGVNCTEVPVAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEHVNNSY
ECDIPIGAGICASYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTI
SVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLNRALTGIAVEQDKNTQE
VFAQVKQIYKTPPIKDFGGFNFSQILPDPSKPSKRSFIEDLLFNKVTLADAGFIKQYGDC
LGDIAARDLICAQKFNGLTVLPPLLTDEMIAQYTSALLAGTITSGWTFGAGAALQIPFAM
QMAYRFNGIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTASALGKLQDVVNQNAQALN
TLVKQLSSNFGAISSVLNDILSRLDKVEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRA
SANLAATKMSECVLGQSKRVDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPA
ICHDGKAHFPREGVFVLNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDP
LQPELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDL
QELGKYEQYIKWPWYIWLGFIAGLIAIVMVTIMLCCMTSCCSCLKGCCSCGSCCKFDEDD
SEPVLKGVKLHYT
>QKS65788.1 |surface glycoprotein [Severe acute respiratory syndrome coronavirus 2]
MFVFLVLLPLVSSQCVNLTTRTQLPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFS
NVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYFASTEKSNIIRGWIFGTTLDSKTQSLLIV
NNATNVVIKVCEFQFCNDPFLGVYYHKNNKSWMESEFRVYSSANNCTFEYVSQPFLMDLE
GKQGNFKNLREFVFKNIDGYFKIYSKHTPINLVRDLPQGFSALEPLVDLPIGINITRFQT
LLALRRSYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETK
CTLKSFTVEKGIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNATRFASVYAWNRKRISN
CVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGKIAD
YNYKLPDDFTGCVIAWNSNNLDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGSTPC
NGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVN
FNFNGLTGTGVLTESNKKFLPFQQFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVITP
GTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEHVNNSY
ECDIPIGAGICASYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTI
SVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLNRALTGIAVEQDKNTQE
VFAQVKQIYKTPPIKDFGGFNFSQILPDPSKPSKRSFIEDLLFNKVTLADAGFIKQYGDC
LGDIAARDLICAQKFNGLTVLPPLLTDEMIAQYTSALLAGTITSGWTFGAGAALQIPFAM
QMAYRFNGIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTASALGKLQDVVNQNAQALN
TLVKQLSSNFGAISSVLNDILSRLDKVEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRA
SANLAATKMSECVLGQSKRVDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPA
ICHDGKAHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDP
LQPELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDL
QELGKYEQYIKWPWYIWLGFIAGLIAIVMVTIMLCCMTSCCSCLKGCCSCGSCCKFDEDD
SEPVLKGVKLHYT
>QPB13175.1 |surface glycoprotein [Severe acute respiratory syndrome coronavirus 2]
MFVFLVLLPLVSSQCVNFTTRTQLPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFS
NVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYFASTEKSNIIRGWIFGTTLDSKTQSLLIV
NNATNVVIKVCEFQFCNDPFLGVYYHKNNKSWMESEFRVYSSANNCTFEYVSQPFLMDLE
GKQGNFKNLREFVFKNIDGYFKIYSKHTPINLVRDLPQGFSALEPLVDLPIGINITRFQT
LLALHRSYLIPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETK
CTLKSFTVEKGIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNATRFASVYAWNRKRISN
CVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGKIAD
YNYKLPDDFTGCVIAWNSNNLDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGSTPC
NGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVN
FNFNGLTGTGVLTESNKKFLPFQQFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVITP
GTNTSNQVAVLYQGVNCTEVPVAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEHVNNSY
ECDIPIGAGICASYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTI
SVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLNRALTGIAVEQDKNTQE
VFAQVKQIYKTPPIKDFGGFNFSQILPDPSKPSKRSFIEDLLFNKVTLADAGFIKQYGDC
LGDIAARDLICAQKFNGLTVLPPLLTDEMIAQYTSALLAGTITSGWTFGAGAALQIPFAM
QMAYRFNGIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTASALGKLQDVVNQNAQALN
TLVKQLSSNFGAISSVLNDILSRLDKVEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRA
SANLAATKMSECVLGQSKRVDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPA
ICHDGKAHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDP
LQPELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDL
QELGKYEQYIKWPWYIWLGFIAGLIAIVMVTIMLCCMTSCCSCLKGCCSCGSCCKFDEDD
SEPVLKGVKLHYT
